Why r/Programming Is Cracking Down on AI-Generated LLM Content In recent months, the surge of AI-driven language models (LLMs) has ...
The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the ...
Build first, understand later.
Image courtesy by QUE.com Why r/Programming Is Cracking Down on AI-Generated LLM Content In recent months, the surge of ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...
MUMBAI: Natco Pharma has heralded what could become an intense pricing war in India’s pharmaceutical sector by offering its generic version of semaglutide at 90% cheaper than the original weight-loss ...
At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...
There's a power to video game quotes that can't be quantified. A combat bark can be immortalized as a meme. A monologue can land with the force of a thousand meteors, knowing the journey you've had to ...
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...
Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients' homes in return for ...
The amount of data we produce every single day is honestly hard to wrap your head around. According to a 2018 piece by Forbes ...